series-c-plus
Stage
About
Igenica is a biopharmaceutical company based in Burlingame, California that discovers and develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The company uses patient-based discovery approaches and integrated platforms to identify and prioritize novel oncology targets.
Explore Igenica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.